EP3962479
KCNT1 INHIBITORS AND METHODS OF USE
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.5.2020:
24.7.2024:
20802501.5
:
30.4.2040
:
KCNT1 INHIBITORS AND METHODS OF USE
1.5.2020
24.7.2024
:
Praxis Precision Medicines, Inc.:
99 High Street, 30th Floor, Boston, MA 02110, US
:
MARTINEZ BOTELLA, Gabriel:
Cambridge, MA 02142, US
:
GRIFFIN, Andrew, Mark:
Cambridge, MA 02142, US
:
CHARIFSON, Paul, S.:
Cambridge, MA 02142, US
:
REDDY, Kiran:
Cambridge, MA 02142, US
:
KAHLIG, Michael, Kristopher Mathieu:
Cambridge, MA 02142, US
:
MARRON, Brian, Edward:
Cambridge, MA 02142, US
:
201962842855 P:
3.5.2019:
US
:
201962842858 P:
3.5.2019:
US
:
201962842861 P:
3.5.2019:
US
:
202062982858 P:
28.2.2020:
US
:
US2020031039:
1.5.2020
:
A61K 31/4192, A61K 31/015, A61K 31/16, C07C 13/465, C07D 249/04